Roberta D’Arrigo - Concepedia

Author

Roberta D’Arrigo

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Also Known As

Fabio Mercurio, I Abbate, R D'Arrigo, R DARRIGO, R d'Arrigo, R. D'Arrigo, R. D’Arrigo, Roberta D'Arrigo, Roberta D'arrigo, Roberta D’Arrigo

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani University of Rome Tor Vergata Center for Prevention and Treatment of Infections Istituto Superiore di Sanità University of Calabria

About

Roberta D’Arrigo is an author at Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	659
2	Public Health	2	2	53
3	Health Sciences	1	1	30
4	Natural Sciences	1	1	57
5	Biochemistry	1	1	57

Roberta D’Arrigo

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization and structural analysis of HIV-1 integrase conservation. Francesca Ceccherini‐Silberstein, Isabelle Malet, Roberta D’Arrigo, PubMed Hiv-1 Integrase ConservationHiv-1 IntegraseHuman RetrovirusPathogenesisImmunology	2009	145
HIV-1 and HCV sequences from Libyan outbreak Túlio de Oliveira, Oliver G. Pybus, Andrew Rambaut, Nature Human RetrovirusVirologyHcv SequencesChronic Viral InfectionHiv	2006	122
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus Domenico Maione, Carlo Della Rocca, Patrizia Giannetti, Proceedings of the National Academy of Sciences Viral PathogenesisImmunologyGene DeliveryBiomedical EngineeringImmunotherapy	2001	88
Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels Maria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, Clinical Infectious Diseases	2014	86
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure Francesca Ceccherini‐Silberstein, Fulvio Erba, Federico Gago, AIDS	2004	69
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors Francesca Ceccherini‐Silberstein, Isabelle Malet, Lavinia Fabeni, Journal of Antimicrobial Chemotherapy	2010	62
High Sequence Conservation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase under Drug Pressure despite the Continuous Appearance of Mutations Francesca Ceccherini‐Silberstein, Federico Gago, Maria Mercedes Santoro, Journal of Virology Viral ReplicationImmunologyHiv-1 Rt ActivityMolecular BiologyInvariant Amino Acids	2005	57
Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing Daniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, The Journal of Infectious Diseases	2012	54
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon Joseph Fokam, Romina Salpini, Maria Mercedes Santoro, Archives of Virology Primary ImmunodeficiencyType-1 Protease-reverse TranscriptaseHuman RetrovirusImmunologyAntiviral Therapy	2011	53
Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120V3signatures in the regulation of Co-Receptor usage Salvatore Dimonte, Fabio Mercurio, Valentina Svicher, Retrovirology	2011	50

Page 1